Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
651-01-005 / 651-01-005 ISMRM Abstract

The performance of MR cytometry imaging in differentiating high- and low-grade bladder cancer

Primary: Body - Urogenital
Secondary: Diffusion - Microstructure
651-01-005 · Pelvic MRI: Bladder, Endometrium, and Rectum · Thursday, 14 May, 8:30 AM–10:06 AM · Power Pitch Theatre 1
651-01-005 · Pelvic MRI: Bladder, Endometrium, and Rectum · Thursday, 14 May, 8:30 AM–10:06 AM · Power Pitch Theatre 1
Keywords: MR cytometry Microstructural imaging Diffusion-weighted MRI Bladder cancer Oscillating gradient spin-echo
Accepted
Li Chen 1, Chaoyang Jin2, Erjia Guo1, Fan Liu3, Xiaoyu Jiang2,4, Zhengyu Jing1, Junzhong Xu5,6, Hua Guo3, Gumuyang Zhang1, Huadan Xue1, Diwei Shi7,8, Hao Sun1
1Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
2Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, United States of America
3Tsinghua University, Beijing, China
4Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, United States of America
5Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, United States of America
6Department of Biomedical Engineering, Vanderbilt University, Nashville, United States of America
7Research Institute of Tsinghua University in Shenzhen, China
8Tsinghua Shenzhen International Graduate School, Tsinghua University, Beijing, China
Presenting Author: Li Chen

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024;384:e076743. Published 2024 Feb 12. doi:10.1136/bmj-2023-076743 [doi]
2. Popli S, Durant AM, Tyson M, Singh P. Current State of Bladder Preservation in High Grade Non-Muscle Invasive Bladder Cancer and Localized Muscle Invasive Bladder Cancer. Curr Oncol Rep. 2025;27(6):761-773. doi:10.1007/s11912-025-01657-3 [doi]
3. Yoshida S, Takahara T, Kwee TC, Waseda Y, Kobayashi S, Fujii Y. DWI as an Imaging Biomarker for Bladder Cancer. AJR Am J Roentgenol. 2017;208(6):1218-1228. doi:10.2214/AJR.17.17798 [doi]
4. Liu F, Wu L, Luo X, et al. Evaluating the Diagnostic Performance of MR Cytometry Imaging in Differentiating Benign and Malignant Breast Tumors. J Magn Reson Imaging. 2025;62(2):521-533. doi:10.1002/jmri.29757 [doi]
5. Zhao Y, Zhao F, Cheng M, et al. Risk Stratification Prediction of Endometrial Cancer Using Microstructural Mapping Based on Time-Dependent Diffusion MRI. Cancer Sci. 2025;116(6):1627-1637. doi:10.1111/cas.70036 [doi]
6. Wu D, Jiang K, Li H, et al. Time-Dependent Diffusion MRI for Quantitative Microstructural Mapping of Prostate Cancer. Radiology. 2022;303(3):578-587. doi:10.1148/radiol.211180 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/651-01-005